Send to

Choose Destination
Bioorg Med Chem Lett. 2013 Feb 1;23(3):702-5. doi: 10.1016/j.bmcl.2012.11.100. Epub 2012 Dec 11.

Additional acetyl cholinesterase inhibitory property of diaryl pyrazoline derivatives.

Author information

Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi 835215, India.


MAO-B and AChE are the two validated targets for Alzheimer's disease. In pursuit of a single molecule hitting both the targets, we explored a set of previously reported extremely potent MAO-B selective inhibitors, for their additional AChE inhibitory activity. We performed molecular docking studies that formed the basis for in vitro enzyme assay, and provided necessary insights into their binding mode. Most of the compounds were found active at nano molar range, and are consistent with the docking results. The identified dual acting lead molecules may provide the basis for further exploring these chemical moieties.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center